Summary
The product Oxymetholone 25 mg, manufactured by Unique Pharma, underwent independent testing to confirm its authenticity and potency. The sample, identified by batch number UN66447 exp 02/2026, was submitted by the reseller Opitropin.EU and analyzed by Janoshik Analytical, a laboratory specializing in pharmaceutical quality control. The analysis measured the presence of Oxymetholone, with a concentration of 22.24 mg, which is -11.04% below the labeled claim of 25 mg.
The testing process began on 18 June 2024, with the sample received on 20 June 2024, and analysis completed on 21 June 2024. While the results confirm the presence of Oxymetholone, the underdosing raises concerns regarding product consistency. This report is intended as an educational resource to promote harm reduction and informed decision-making.
Detailed Report
Product Overview
- Manufacturer: Unique Pharma
- Product Name: Oxymetholone 25 mg
- Active Ingredient: Oxymetholone
- Batch Number: UN66447 exp 02/2026
- Expiration Date: February 2026
- Delivery Method: Oral Tablet
Sample Acquisition and Testing
- Task Number: #44222
- Testing Ordered: 18 June 2024
- Sample Received: 20 June 2024
- Analysis Conducted By: Janoshik Analytical
- Product Submitted By: Opitropin.EU (Reseller)
- Analysis Paid For By: Opitropin.EU
Testing Results
- Specification: 25 mg (as stated on the label)
- Measured Concentration: 22.24 mg
- Accuracy: 88.96% (-2.76 mg below label claim)
- Variance: -11.04%
Verification Details
- Verification URL: https://janoshik.com/tests/44222_NPKXDVR7Y5GM
- Originally Published: https://thinksteroids.com/community/posts/3118518/
Evaluation of Reseller-Submitted Testing
This analysis confirms the relative accuracy of the tested product but warrants scrutiny due to its submission and funding by the reseller Opitropin.EU. Resellers may selectively choose optimal batches for testing, which might not reflect overall market consistency. Further third-party testing across multiple batches is recommended to validate the findings comprehensively.
Conclusion
The analysis indicates that Oxymetholone 25 mg by Unique Pharma is slightly underdosed, with a measured concentration of 22.24 mg, reflecting a -11.04% variance from the label claim. This deviation suggests potential inconsistencies in production. Consumers should remain cautious and consider third-party verification for consistent assurance.
Disclaimer
This report is published for educational and harm reduction purposes. Reseller-submitted testing may introduce biases; however, it still provides valuable insights when critically evaluated alongside independent third-party results. Readers are encouraged to use this information responsibly.
